Indian markets faced a downturn with Nifty 50 showing only 4% PAT growth in 9MFY25. Despite modest earnings, four companies ...
The Nifty 50 index has remained under pressure this year and formed a death cross pattern, pointing to more downward momentum ...
The Nifty-50 index has reported a subdued performance for the third straight quarter, posting a single-digit year-on-year ...
For 2025 so far, the Nifty Smallcap 100 index has tanked 17.58 percent, while the midcap index has cracked 11.82 percent.
Motilal Oswal said that the recent correction in broader markets factors into some of the potential disappointments in ...
Banks, telecom and healthcare are Citi's preferred themes after a "meaningful" market correction from peak levels is set to ...
Amidst mixed global signals, Indian indices started on a weak note and saw continued selling pressure throughout the day.
Glenmark Pharmaceuticals rose 5.7% after the company reported a 300.2% sales growth in India for the third quarter.
FY25 results show growth in various sectors, with challenges like consumption slowdown and higher input costs.
The Nifty 50, a benchmark index representing India's top 50 companies by market capitalization, has witnessed its valuation ...
The Nifty 50 and Sensex indices extended their losing streak on February 17, marking the ninth consecutive session of ...
Nifty-50 index reports subdued Q3FY25 earnings growth, raising concerns over corporate sustainability amid economic ...